Biotechnology Value Fund II, Director: Kymera Therapeutics KYMR Buy · Filed 23/01/13

Trade details

Type: Insider buy
Amount: $497,090.88
Shares · price: 15,912 sh · $31.24 a share
Held after: 1,888,351 sh
Stock: Kymera Therapeutics KYMR
Person: Biotechnology Value Fund IIDirector
Trade date: 23/01/12
Filed: 23/01/13
Days to filing: 1 days

10 insiders bought this week

Insiders buying this week: 10 insiders
Holding change: +0.8%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/13~23/02/11

Biotechnology Value Fund II's recent trades

Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31

Biotechnology Value Fund II, Director — bought $497.1K of Kymera Therapeutics KYMR · 15,912 sh @ $31.24 | Whalegun